Literature DB >> 11096756

Cardiac Causes of Stroke.

.   

Abstract

At least 20% of all ischemic strokes are cardioembolic. Cardiac conditions that cause cerebral embolism are classified as major or minor depending on whether the causal link has or has not been fully established between the underlying cardiac condition and the stroke. Atrial fibrillation, acute myocardial infarction, valvular heart disease, infective endocarditis, nonbacterial thrombotic endocarditis, and atrial myxoma are the main cardiac causes of cerebral embolism. Patent foramen ovale, atrial septal aneurysm, mitral valve prolapse, mitral annular calcification, calcific aortic stenosis, and mitral valve strands are cardiac conditions with a potential causal link to cerebral embolism, but until now, either they have been found to be poor predictors of recurrent stroke or their risk of recurrent stroke is unknown. The management of patients with a stroke of cardiac source is twofold: 1) treatment of the acute phase of stroke and 2) prophylactic treatment of recurrent thromboembolism. When possible, primary prevention of cerebral embolism should be recommended, particularly in cardiac conditions with known high risk of stroke (eg, atrial fibrillation, mitral stenosis, or presence of mechanical prosthetic heart valves).

Entities:  

Year:  2000        PMID: 11096756     DOI: 10.1007/s11940-000-0048-4

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  47 in total

1.  Mitral valve strands and the risk of ischemic stroke in elderly patients. The French Study of Aortic Plaques in Stroke (FAPS) Investigators.

Authors:  A Cohen; C Tzourio; C Chauvel; B Bertrand; I Crassard; Y Bernard; L Goullard; S Falcon; M G Bousser; P Amarenco
Journal:  Stroke       Date:  1997-08       Impact factor: 7.914

2.  Randomized trial of low molecular weight heparin (dalteparin) in prevention of left ventricular thrombus formation and arterial embolism after acute anterior myocardial infarction: the Fragmin in Acute Myocardial Infarction (FRAMI) Study.

Authors:  F Kontny; J Dale; U Abildgaard; T R Pedersen
Journal:  J Am Coll Cardiol       Date:  1997-10       Impact factor: 24.094

3.  Lack of evidence of an association between mitral-valve prolapse and stroke in young patients.

Authors:  D Gilon; F S Buonanno; M M Joffe; M Leavitt; J E Marshall; J P Kistler; R A Levine
Journal:  N Engl J Med       Date:  1999-07-01       Impact factor: 91.245

4.  Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants.

Authors:  E Ferrari; R Vidal; T Chevallier; M Baudouy
Journal:  J Am Coll Cardiol       Date:  1999-04       Impact factor: 24.094

5.  Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism.

Authors:  S G Timsit; R L Sacco; J P Mohr; M A Foulkes; T K Tatemichi; P A Wolf; T R Price; D B Hier
Journal:  Stroke       Date:  1992-04       Impact factor: 7.914

6.  Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke.

Authors:  A Cohen; C Tzourio; B Bertrand; C Chauvel; M G Bousser; P Amarenco
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

7.  Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy.

Authors:  P Tornos; B Almirante; S Mirabet; G Permanyer; A Pahissa; J Soler-Soler
Journal:  Arch Intern Med       Date:  1999-03-08

Review 8.  Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.

Authors:  P D Stein; J S Alpert; J E Dalen; D Horstkotte; A G Turpie
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

9.  Protruding atheromas in the thoracic aorta and systemic embolization.

Authors:  P A Tunick; J L Perez; I Kronzon
Journal:  Ann Intern Med       Date:  1991-09-15       Impact factor: 25.391

10.  Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction.

Authors:  A G Turpie; J G Robinson; D J Doyle; A S Mulji; G J Mishkel; B J Sealey; J A Cairns; L Skingley; J Hirsh; M Gent
Journal:  N Engl J Med       Date:  1989-02-09       Impact factor: 91.245

View more
  4 in total

1.  Risks of tumor embolization in the presence of an unrecognized patent foramen ovale: case report.

Authors:  Michael Bruce Horowitz; Ricardo Carrau; Donald Crammond; Emanuel Kanal
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

2.  Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  James F Meschia; Cheryl Bushnell; Bernadette Boden-Albala; Lynne T Braun; Dawn M Bravata; Seemant Chaturvedi; Mark A Creager; Robert H Eckel; Mitchell S V Elkind; Myriam Fornage; Larry B Goldstein; Steven M Greenberg; Susanna E Horvath; Costantino Iadecola; Edward C Jauch; Wesley S Moore; John A Wilson
Journal:  Stroke       Date:  2014-10-28       Impact factor: 7.914

Review 3.  Stroke of a cardiac myxoma origin.

Authors:  Shi-Min Yuan; Gulimila Humuruola
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Mar-Apr

4.  Giant left atrial myxoma - literature review and case presentation.

Authors:  Victor Cornel Raicea; Horaţiu Suciu; Andrei Dan Raicea; Gheorghe Cosmin Macarie; Tibor Mezei; Maria Smaranda Maier
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.